venetoclax
roche,abbvie
['leusm', 'venetoclax']
congress #eha2023 | discusses a phase ii trial of mini-hyper-cvd+venetoclax for pts with r/r ph-ve all. n=23, 1 pt was in cr at enrollment. 55% responded to therapy, 9 in cr. orr in 18 pts who had bone marrow assessment after cr =67%. #leusm #allsm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm